Serologic diagnosis of West Nile virus infection

Expert Review of Molecular Diagnostics

Volumn 3, Issue 6, 2003, Pages 733-741

  Shi, Pei Yong ^a   Wong, Susan J ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

Arbovirus; Diagnosis; Flavivirus; Serologic diagnosis; West Nile virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

BLOOD TRANSFUSION; BREAST FEEDING; DENGUE VIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FLUORESCENT ANTIBODY TECHNIQUE; HEMAGGLUTINATION INHIBITION TEST; IMMUNOASSAY; LABORATORY INFECTION; MENINGOENCEPHALITIS; MOSQUITO; NONHUMAN; ORGAN TRANSPLANTATION; PLAQUE REDUCTION NEUTRALIZATION TEST; RELIABILITY; REVIEW; SERODIAGNOSIS; ST LOUIS FLAVIVIRUS; UNITED STATES; VACCINATION; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; WESTERN HEMISPHERE;

ANIMALS; ANTIBODIES, VIRAL; HUMANS; SEROLOGIC TESTS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 0242641480     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.3.6.733     Document Type: Review

References (69)

1. th Edition. Knipe DM, Howley PM (Eds), Lippincott William & Wilkins, PA, USA, 991-1042 (2001).
2. th Edition. Knipe DM, Howley PM (Eds). Lippincott William & Wilkins, PA, USA, 1043-1126 (2001).
3. Chambers TJ, Hahn CS, Galler R et al. Flavivirus genome organization, expression and replication. Ann. Rev. Microbiol. 44, 649-688 (1990).
4. Brinton MA. The molecular biology of West Nile virus: a new invader of the Western Hemisphere. Annu. Rev. Microbiol. 56, 371-402 (2002). Comprehensive review of West Nile virus (WNV) molecular biology.
5. Smithbum KC, Hughes TP, Burke AW et al. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. 20, 471-492 (1940).
6. Petersen LR, Roehrig JT. West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis. 7, 611-614 (2001).
7. Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic: United States, January-November 2002. Morb. Mortal. Wkly Rep. 51, 1129-1133 (2002).
8. Davis B, Chang G, Cropp B et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75, 4040-4047 (2001). Recombinant envelope and premembrane proteins of WNV secreted from a plasmid-transformed COS cell line can be used as antigens in ELISAs.
9. Monath T. Prospects for development of a vaccine against the West Nile virus. Ann. NY Acad. Sci. 951, 1-12 (2001).
10. Bernard KA, Maffei JG, Jones SA et al. West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg. Infect. Dis. 7, 679-685 (2001).
11. Nasci R, White D, Stirling H et al. West Nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerg. Infect. Dis. 7, 626-630 (2001).
12. Centers for Disease Control and Prevention. Guidelines for surveillance, prevention and control of West Nile virus infection - United States. Morb. Mortal. Wkly Rep. 49, 25-28 (2000).
13. Shi PY, Kramer LD. Molecular detection of West Nile virus RNA. Expert Rev. Mol. Diagn. 3, 357-366 (2003).
14. Shi PY, Kauffman EB, Ren P et al. High-throughput detection of West Nile virus RNA. J. Clin. Microbiol. 39, 1264-1271 (2001).
15. Lanciotti RS, Kerst AJ, Nasci RS et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes and avian samples by a TaqMan reverse transcriptase-PCR assay. J. Clin. Microbiol. 38, 4066-4071 (2000).
16. Lanciotti R, Kerst A. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J. Clin. Microbiol. 39, 4506-4513 (2001).
17. Briese T, Glass WG, Lipkin WI. Detection of West Nile virus sequences in cerebrospinal fluid. Lancet 355, 1614-1615 (2000).
18. Centers for Disease Control and Prevention. Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion - Michigan, 2002. Morb. Mortal. Wkly Rep. 51, 879 (2002).
19. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breastfeeding - Michigan, 2002. Morb. Mortal. Wkly Rep. 51, 877-878 (2002).
20. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection - New York, 2002. Morb. Mortal. Wkly Rep. 51, 1135-1136 (2002).
21. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections - United States, 2002. Morb. Mortal. Wkly Rep. 51, 1133-1135 (2002).
22. Heinz FX, Roehrig JT. Flaviviruses. In: Immunochemistry of Viruses. Elsevier, Amsterdam, The Netherlands, 289-305 (1990).
23. Young PR, Hilditch PA, Bletchly C et al. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38, 1053-1057 (2000).
24. Kuno G, Vorndam AV, Gubler DJ et al. Study of antidengue NS1 antibody by western blot. J. Med. Virol. 32, 102-108 (1990).
25. Shu PY, Chen LK, Chang SF et al. Potential application of nonstructural protein NS1 serotype-spicific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J. Clin. Microbiol. 40, 1840-1844 (2002). Dengue nonstructural (NS)1-based ELISA can be used to differentiate primary and secondary dengue infection and serotypes of primary dengue infection.
26. Rothman AL, Kurane I, Lai CJ et al. Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T-lymphocytes. J. Virol. 67, 801-806 (1993).
27. Hill AB, Lobigs M, Blanden RV et al. The cellular immune response to flaviviruses. In: Viruses and the Cellular Immune Response. Thomas DB (Ed.), Marcel Dekker, NY, USA, 363-388 (1993).
28. Wong S, Boyle R, Demarest V et al. An immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and flavivirus vaccination. J. Clin. Microbiol. 41, 4217-4223 (2003). First report to use purified NS5 protein of WNV as an antigen to perform virus type-specific serological diagnosis of flaviviruses.
29. Tardei G, Ruta S, Chitu V et al. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. J. Clin. Microbiol. 38, 2232-2239 (2000).
30. Roehrig JT, Nash D, Malden B et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. 9, 376-379 (2003). Demonstrated that and-WNV IgM in serum persists in many patients for 3-6 months after symptom onset and can extend beyond 15 months.
31. Beaty BJ, Calisher CH, Shope RE. Diagnostic procedures for viral, rickettsial and chlamydial infections. Arboviruses 7, 204-205 (1995).
32. Martin DA, Muth DA, Brown T et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J. Clin. Microbiol. 38, 1823-1826 (2000). Evaluated and standardized a combined IgM antibody capture-ELISA to identify virus infections caused by arboviruses from three virus families: the Togaviridae, Flaviviridae and Bunyaviridae.
33. Martin DA, Biggerstaff BJ, Allen B et al. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin. Diagn. Lab. Immunol. 9, 544-549 (2002).
34. Roehrig JT, Mathews JH, Trent DW. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology 128, 118-126 (1983).
35. Nash D, Mostashari F, Fine A et al. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344, 1807-1814 (2001).
36. Johnson AJ, Langevin S, Wolff KL et al. Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 41, 2002-2007 (2003).
37. Monath TP, Nystrom RR, Bailey RE et al. Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J. Clin. Microbiol. 20, 784-790 (1984).
38. Lhullier M, Sarthou JL. Interet des IgM anti-amariles dans le diagnostic et la surveillance epidemiologique de la fievre jaune. Ann. Virol. 134, 349-359 (1983).
39. Mortimer PP. Antibody tests: progress and pitfalls. Clin. Diagn. Virol. 5, 131-136 (1996).
40. Johnson AJ, Martin DA, Karabatsos N et al. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay J. Clin. Microbiol. 38, 1827-1831 (2000).
41. Kaufman BM, Summers PL, Dubois DR et al. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36, 427-434 (1987).
42. Gubler D, Campbell G, Nasci R et al. West Nile virus in the United States: guidelines for detection, prevention and control. Viral Immunol. 13, 469-475 (2000).
43. Ebel G, Dupuis A, Nicholas D et al. Detection by enzyme-linked immunosorbent assay of antibodies to West Nile virus in birds. Emerg. Infect. Dis. 8, 979-982 (2002).
44. Pillot J. The year of Pasteur: from the concept of antibody and antigen by Bordet (1895) to the ELISA. What future for immunological diagnosis? Clin. Diagn. Virol. 5, 191-196 (1996).
45. Koraka P, Zeller H, Niedrig M et al. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect. 4, 1209-1215 (2002).
46. Chen W-R, Rico-Hesse R, Tesh R. A new genotype of Japanese encephalitis virus from Indonesia. Am. J. Trop. Med. Hyg. 47, 61-69 (1992).
47. Casals J, Brown LV. Hemagglutination with anthropod-borne viruses. J. Exp. Med. 99, 429-449 (1954).
48. Weingartl HM, Drebot M, Hubakek Z et al. Comparison of assays for the detection of West Nile virus antibodies in chicken serum. Can. J. Vet. Res. 67, 128-132 (2003).
49. Beaty BJ, Callisher CH, Shope RE. Arboviruses. In: Diagnostic Pocedures for Viral, Rickettsial and Chlamydial Infection, 7th Edition. Lennette EH, Lennette DH, Lenette ET (Eds), American Public Health Association, WA, USA (1995).
50. Lindsey HS, Calisher CH, Mathews JH. Serum dilution neutralization test for California group virus identification and serology. J. Clin. Microbiol. 4, 503-510 (1976).
51. Kellar KL, Kalwar KA, Dubous KA et al. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45, 27-36 (2001). Describes multiplexed sandwich immunoassays for eight cytokines by coupling cytokine-specific capture antibodies to beads with different emission spectra.
52. Mandy FF, Nakamaura T, Bergeron M et al. Overview and application of suspension array technology. Clin. Lab. Med. 21, 713-729 (2001).
53. Rappole J, Derrickson S, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg. Infect. Dis. 6, 319-328 (2000).
54. Centers for Disease Control and Prevention. Update: surveillance for West Nile virus in overwintering mosquitoes: New York, 2000. Morb. Mortal. Wkly Rep. 49, 178-179 (2000).
55. Chamberlain R. History of St. Louis encephalitis. In: St. Louis Encephalitis. Monath TP (Ed.), American Public Health Association, WA, USA, 3-61 (1980).
56. Huang C, Slater B, Campbell W et al. Detection of arboviral RNA directly from mosquito homogenates by reverse-transcription-polymerase chain reaction. J. Virol. Methods 94, 121-128 (2001).
57. Johnson D, Ostlund E, Pedersen D et al. Detection of North American West Nile virus in animal tissue by a reverse transcription-nested polymerase chain reaction assay. Emerg. Infect. Dis. 7, 739-741 (2001).
58. Churdboonchart V, Bhamarapravati N, Peampramprecha S et al. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 44, 481-493 (1991).
59. Qureshi AA, Trent DW. Group B arbovirus structural and nonstructural antigens. Infect. Immunity 8, 993-999 (1973). Demonstrated that NS proteins of dengue, St. Louis encephalitis or WNV react with only homologous sera but not with heterologous sera.
60. Shu PY, Chen LK, Chang SF et al. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of MAb-based indirect ELISA to differentiate infection from vaccination. Vaccine 19, 1753-1763 (2001).
61. Shu PY, Chen LK, Chang SF et al. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 62, 224-232 (2000).
62. Blitvich BJ, Bowen RA, Marlenee NL, Hall RA, Bunning ML, Beaty BJ. Epitope-blocking enzyme-linked immunosorbent assays for detection of West Nile virus antibodies in domestic mammals. J. Clin. Microbiol. 41, 2676-2679 (2003).
63. Centers for Disease Control and Prevention. Inactivated Japanese Encephalitis Virus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 42, 1-15 (1993).
64. Zinkernagel RM, LaMarre A, Ciurea A et al. Neutralizing antiviral antibody responses. Adv. Immunol. 79, 1-53 (2001).
65. Brinton MA, Kurane I, Mathew A et al. Immune mediated and inherited defenses against flaviviruses. Clin. Diagn. Virol. 10, 129-139 (1998).
66. Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769-7773 (2001).
67. Binley JM, Arshad H, Fouts TR, Moore JP. An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus Type 1. AIDS Res. Hum. Retroviruses 13, 1007-1015 (1997).
68. Thomas HI, Wilson S, O'Toole CM et al. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin. Exp. Immunol. 103, 185-191 (1996).
69. Kayser M, Klein H, Paasch I, Pilaski J, Blenk H, Heeg K. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine. J. Med. Virol. 17, 35-45 (1985).